JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY, Год журнала: 2025, Номер 8(4), С. 238 - 240
Опубликована: Апрель 1, 2025
Язык: Английский
JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY, Год журнала: 2025, Номер 8(4), С. 238 - 240
Опубликована: Апрель 1, 2025
Язык: Английский
JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY, Год журнала: 2025, Номер unknown
Опубликована: Фев. 13, 2025
Abstract Almost every facet of modern biomedical research involves artificial intelligence (AI). This ACCP commentary forecasts the role AI in clinical pharmacy and scholarship. The potential benefits/opportunities together with limitations/challenges are reviewed for stages scientific method including (1) developing question(s), study design, execution; (2) data analysis; (3) reporting dissemination research. Benefits opportunities include streamlining hypothesis generation facilitating overcoming limitations traditional statistical analysis techniques, manuscript development dissemination, expediting peer review. Limitations challenges introduction biases subject recruitment; false information, also known as “AI hallucinations”; concern “black box” analyses that difficult to validate; legal liabilities; lack accountability; need investigators ensure accuracy integrity AI‐generated content. In summary, rapid progress capabilities has great revolutionize accelerate scholarship; however, it is imperative recognize mitigate introduced by AI.
Язык: Английский
Процитировано
1JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY, Год журнала: 2025, Номер 8(4), С. 238 - 240
Опубликована: Апрель 1, 2025
Язык: Английский
Процитировано
0